Top Institutions in Ophthalmology - Retinal Cell Therapy
Leading institutions conduct early-phase clinical trials involving stem cell-derived RPE transplantation, utilizing advanced surgical delivery techniques and long-term visual acuity and anatomical assessments to evaluate safety and efficacy in GA patients.
-
#1
University of Cincinnati Medical Center
Cincinnati, OH
Home to the principal investigator Dr. Christopher D. Riemann, the institution leads clinical trials on OpRegen RPE cell therapy with extensive expertise in vitreoretinal surgery and translational research in AMD.
Key Differentiators
- Ophthalmology
- Retinal Surgery
- Stem Cell Therapy
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Renowned for pioneering research in retinal degenerative diseases and stem cell therapies, with multiple ongoing clinical trials targeting AMD and geographic atrophy.
Key Differentiators
- Ophthalmology
- Retinal Diseases
- Cell Therapy Research
-
#3
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Top-ranked ophthalmology center with a focus on innovative treatments for AMD, including stem cell and gene therapies, and extensive clinical trial experience in retinal diseases.
Key Differentiators
- Ophthalmology
- Retina
- Regenerative Medicine
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Known for cutting-edge research in retinal diseases and regenerative medicine, with active involvement in stem cell therapy trials for AMD and GA.
Key Differentiators
- Ophthalmology
- Retinal Degeneration
- Stem Cell Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







